Status:

COMPLETED

Pre-exposure Prophylaxis: A Miracle Drug or a Moral Hazard

Lead Sponsor:

New York University

Conditions:

Syphilis

Chlamydia

Eligibility:

MALE

18+ years

Brief Summary

The investigators study the behavioral consequences of Pre-exposure Prophylaxis or PrEP on sexual health behaviors, sexual health outcomes, and partner selection preferences. The study collects observ...

Detailed Description

See statistical analysis plan.

Eligibility Criteria

Inclusion

  • 18 years or above
  • living in the London, New York, Toronto or Sydney metro area
  • self-reported sex at birth is male
  • reported ever having sex with a male

Exclusion

  • not meeting the inclusion criteria

Key Trial Info

Start Date :

January 20 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 15 2020

Estimated Enrollment :

2647 Patients enrolled

Trial Details

Trial ID

NCT04325555

Start Date

January 20 2020

End Date

March 15 2020

Last Update

October 14 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

New York University Abu Dhabi

Abu Dhabi, United Arab Emirates, 00000

Pre-exposure Prophylaxis: A Miracle Drug or a Moral Hazard | DecenTrialz